CLBT · Cellebrite DI Ltd
United States · RS rating 40 · As of 2026-11-03
| Price | 12.25 USD |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 40 / 81 / 29 / 32 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 10 / 18 |
| Industry group (rank) | Comp Sftwr-Spec Enterprs (132) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | +2.2% |
| Distance from 52-week high | +36.5% |
| Market cap (USD) | $3.2B |